Gc protein-derived macrophage activating factor (GcMAF) https://greenmedinfo.com/category/keywords/Gc%20protein-derived%20macrophage%20activating%20factor%20%28GcMAF%29 en GcMAF shows therapeutic potency in the treatment of Multiple sclerosis. https://greenmedinfo.com/article/gcmaf-shows-therapeutic-potency-treatment-multiple-sclerosis n/a PMID:  Anticancer Res. 2016 Jul ;36(7):3771-4. PMID: 27354653 Abstract Title:  Case Report: GcMAF Treatment in a Patient with Multiple Sclerosis. Abstract:  BACKGROUND/AIM: Gc protein-derived macrophage-activating factor (GcMAF) has various functions as an immune modulator, such as macrophage activation, anti-angiogenic activity and anti-tumor activity. Clinical trials of second-generation GcMAF demonstrated remarkable clinical effects in several types of cancers. Thus, GcMAF-based immunotherapy has a wide application for use in the treatment of many diseases via macrophage activation that can be used as a supportive therapy. Multiple sclerosis (MS) is considered to be an autoimmune disorder that affects the myelinated axons in the central nervous system (CNS). This study was undertaken to examine the effects of second-generation GcMAF in a patient with MS. RESULTS: This case study demonstrated that treatments of GcMAF in a patient with MS have potent therapeutic actions with early beneficial responses, especially improvement of motor dysfunction. CONCLUSION: GcMAF shows therapeutic potency in the treatment of MS. https://greenmedinfo.com/article/gcmaf-shows-therapeutic-potency-treatment-multiple-sclerosis#comments Gc protein-derived macrophage activating factor (GcMAF) Multiple Sclerosis Immunomodulatory Gc protein-derived macrophage activating factor (GcMAF) Immunomodulatory Multiple Sclerosis Significant Treatment Outcome Human: Case Report Mon, 19 Jun 2017 19:03:46 +0000 greenmedinfo 149335 at https://greenmedinfo.com